Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma

出版年份 2018 全文链接

标题

作者

关键词

出版物

Volume 24, Issue 9, Pages 2082-2091

出版商

American Association for Cancer Research (AACR)

发表日期

2018-02-26

DOI

10.1158/1078-0432.ccr-17-0723

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started